CLINICAL_TRIALS ClinicalTrials.gov record update

Clinical Study of Chimeric Mesothelin Antigen Receptor-modified T Cells in Relapsed and/or Chemotherapy Refractory Malignancies

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT02580747
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:36:05.212634+00:00
Published At: 2015-10-20T00:00:00+00:00
Record Updated At: 2015-10-20
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Malignant Mesothelioma", "Pancreatic Cancer", "Ovarian Tumor", "Triple Negative Breast Cancer", "Endometrial Cancer", "Other Mesothelin Positive Tumors"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2015-10-20"
protocolSection.identificationModule.nctId: "NCT02580747"
protocolSection.identificationModule.officialTitle: "Clinical Study of Chimeric Mesothelin Antigen Receptor-modified T Cells in Relapsed and/or Chemotherapy Refractory Malignancies"
protocolSection.statusModule.overallStatus: "UNKNOWN"
protocolSection.designModule.phases: ["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.